Skip to content

Feasibility study of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma

Feasibility study of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma - Feasibility study of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000032875
Enrollment
5
Registered
2018-07-01
Start date
2018-06-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic lung tumors from adenoid cystic carcinoma

Interventions

None listed

Sponsors

Kanto Neurosurgical Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) diagnosed as metastatic lung tumors from adenoid cystic carcinoma in clinical course 2) measurable tumors 3) a performance status of 0-2

Exclusion criteria

Exclusion criteria: The presence of other primary cancers

Design outcomes

Primary

MeasureTime frame
Toxicity

Countries

Japan

Contacts

Public ContactHiro Sato

Gunma University Graduate School of Medicine Department of Radiation Oncology

h-sato0808@hotmail.co.jp027-220-8383

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026